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ABSTRACT 
 
Looking into the vast threats of possible silent introduction of yellow fever virus into India, we have 
studied the various probable responsible factors, situations and circumstances along-with ways & 
means of ensuring adequate prevention cum control measures in case of any inadvertent identified 
presence of this virus in the Indian territories. Thus recommended evidence based analytical 
approach, designed and implemented in word and spirit, will go a long way in generating confidence 
not only among the beneficiary general population of India, but will also give a sigh of relief from the 
possible grave public health threats of yellow fever to the policy makers, programme managers and 
health functionaries already overloaded with health care challenges of multiple types, dimensions 
and magnitude. A strategic policy initiative is the answer to address the critical issues based on 
suggestions deliberated herein.  
 
Key Words: aedes aegypti index, arbo-viral, cross immunity, ecological barrier, endemic, 
epidemiological triad, surveillance, sylvatic, transovarian 
 
 
INTRODUCTION: 
The international control of yellow fever, one of 
the major medical challenges of the century, 
poses un-assessed public health challenges of 
multifaceted nature towards safety and survival 
of the vulnerable population of developing 
countries like India. In view of the already 
existing favorable geo-social scenario and other 
factors, it becomes imperative to examine in 
detail about the perceived threats of presence 
and subsequent transmission of yellow fever in 
India. If we go by the geographical location of 
India, it is too far away from African and South 
American continents regularly reporting very 
few cases and mortality data of yellow fever 
with possibilities of millions of cases and 
thousands of death going generally unreported 
in the region. Population mobility is a main 
factor in globalization of public health threats 
and risks. 1 
Arbo-viral diseases like Dengue, Japanese 
Encephalitis, West Nile Fever, Kyasanur Forest 
Disease, Chikungunya etc are already 
contributing to the morbidities of varied nature 
and proportion in India. The presence of new 
arbo-viral diseases like yellow fever, being 
reported from any part of the country, may 
become an unwelcome surprise as a public 
health emergency requiring dealing with 
immediate urgent challenges for implementing 
prevention and control measures of 
unprecedented magnitude in terms of the target 
population, fiscal liabilities, mortalities, impact 
on the overall health scenario and lagging 
behind in the achievements of overall 
development goals. 
Despite sustained global cum regional initiatives 
and international measures2-3 i n  t h e  f o r m  o f  
vaccine supply, programme support, 
surveillance, treatment, information education & 
communication initiatives, the containment of 
yellow fever virus to the jungles has not been  
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possible in the Americas and Africas. The 
surprising and sudden reporting of yellow fever 
cases after 34 years of silence in countries like 
Paraguay4 raises alarm about the long term 
threats of yellow fever, even if either it gets 
controlled to the undetectable levels for decades 
or it is not reported at all in the earlier decades. 
While African continent reported 47 cases & 6 
mortalities in year 2008 and 20 cases & 3 
mortalities in year 2009, the Americas reported 
102 cases & 42 mortalities in year 2008 and 55 
cases & 18 mortalities in year 2009 as per reports 
of World Health Organisation.5  Although the 
number of cases officially reported by World 
Health Organisation in January 2011 for the year 
2008 and 2009 in Africas and Americas were 
negligible, but there are an estimated 200,000 
cases and 30,000 deaths worldwide each year.6  
 
MATERIAL & METHOD: 
An exhaustive review of available literature, 
current global scenario, health challenges in 
India, present policy initiatives and impact 
assessment reports of national health 
programmes especially National Vector Borne 
Disease Control Programme was conducted. 
These consolidated findings were also studied 
across spectrum of epidemiological triad along 
with the reach, quality and limitations of present 
health care scenario in India.  
 
RESULT & DISCUSSION: 
The need of hour is to examine extensively the 
points & routes of entry for yellow fever in 
India, the probable shortcomings in prevention 
and control measures and the necessity of an 
integrated public health response system & 
mechanism in place. International travelers 
coming from the endemic countries by air, sea or 
land routes pose direct definite threats since 
leaving even a single traveller un-checked for 
possession of valid ‘international certificate of 
yellow fever vaccination’ at the airport or sea-
port can create havoc, if he/she has been a case 
of yellow fever or has been in the incubation 
period at the time of arrival. He/she can be the 
source of flavivirus flavis infection in the 
humans for generating innumerable 
uncontrolled urban and rural cycles of yellow 
fever in the country.  
In addition, the mosquitoes in the aircrafts and 
ships from the endemic areas may also transmit 
the infection, if no proper & appropriate 
internationally laid down procedures are 
followed for aerosol spray. The possibilities of 
such lapses cannot be ruled out in view of un-
assessed but high volume of travel & transport 
loads from endemic countries. In-transit 
international travelers and unvaccinated cabin 
crew of flights or ships may also go undetected, 
if due precautions and care is not exercised, for 
yellow fever vaccination status. India like any 
other non-endemic country can have no access 
to the real time information of the ‘Aedes 
aegypti index’ in the towns and seaports of 
endemic countries and therefore transmission 
possibilities for yellow fever always do exist 
through cargo or shipment transport by air or 
sea route reaching India within 6 days, the 
incubation period of yellow fever, of departure 
from or through an endemic country. There may 
be cases of non observance of protocol for 
checking of valid ‘International Certificate of 
Yellow Fever Vaccination’ for the travelers 
embarking in India directly from endemic 
countries. Such lapses or laxities may 
inadvertently invite the yellow fever resulting in 
the unbreakable chain of infections & events 
leading to sufferings of unimaginable 
magnitude for the unvaccinated masses of India.  
The initiation of biological warfare by terrorists 
or the enemy countries or a person of 
destructive mindset may either trigger sylvatic 
(monkey-mosquito-monkey) cycle or urban 
(man-mosquito-man) cycle of yellow fever or 
both the cycles simultaneously/in succession. 
Entry of unvaccinated travellers belonging to or 
from endemic countries in India, within 6 days 
of their departure from home country, by 
indirect flight or land route through one or more 
number of neighbouring countries, who may or 
may not strictly adhere to the international 
norms all the times, also requires careful & close 
monitoring at all the international borders.  
The reported transovarian transmission of the 
virus7 in mosquitoes during adverse conditions, 
viz. extended dry seasons, in the absence of 
susceptible hosts may enhance the coverage of 
geographical areas beyond political boundaries 
of the endemic countries to reach the countries 
or areas, which never observed such cases. The 
successiveness of such cycles or events may lead 
to gradual entry of this infection to the 
countries, the travelers from whom are not 
presently required to produce a valid 
‘International Certificate of Yellow Fever 
Vaccination’. Hence, there is an existing  
 
pISSN: 0976 3325 eISSN: 2229 6816 
National Journal of Community Medicine Vol 3 Issue 1 Jan-March 2012  Page 33 
 
 
possibility of silent entry of this infection 
through the incoming travelers or cargo of the 
non-endemic countries to India. India is 
categorized as ‘Yellow Fever Receptive Area’, an 
area in which yellow fever does not exist, but 
where conditions would permit its development 
if introduced.8  And, hence unvaccinated & 
susceptible Indian population, abundant 
presence of aedes aegypti, favourable climatic 
conditions of more than 24 degree Celsius and 
60% relative humidity prevailing over large 
geographic area/during rainy seasons and 
susceptibility of common monkey of India 
(Macacus rhesus and M. sinicus) to yellow fever 
virus are among the key factors which can be 
intervened, as per the presence of one or 
combination of more than one of these factors.  
Above all those reasons cited in the preceding 
paragraphs, the non existence of any quick 
public health response mechanism or adequate 
& immediate availability of yellow fever 
vaccines for curbing propagation of subsequent 
infection from the first suspected/reported case 
of yellow fever in the country is most important 
and needs urgent attention of public health 
authorities. Fostering and sustaining high-level 
political commitment, improving the planning 
and monitoring of immunisation services at all 
levels, adequate community mobilisation, 
efficient coordination of current and future 
immunisation partners 9 along with mitigation 
exercises are required to be necessarily ensured 
for sustainable programme management 
towards prevention and control of yellow fever 
in the country.  
 
RECOMMENDATIONS: 
As evidenced above, there is need of the 
following national initiatives for the near 
absolute protection of the country from entry of 
the dreaded yellow fever virus, if a 
suspected/confirmed case is detected anywhere 
in India/neighbouring countries, as a national 
emergency:  
 (a) Initiate national consultations on drafting of 
the national policy on ‘Prevention and control of 
yellow fever in India’ and finalize it in close 
consultation with the ‘World Health 
Organization’ and experienced ‘Public Health 
Experts’ of the endemic countries;  
(b) Duly approve and implement national 
policy, as agreed through national 
consensus/consultations and drafted as above; 
Develop and ensure a quick and sustainable 
public health response to the emergency 
situations including keeping ‘National and State 
Task Forces’ ready with adequate 
administrative, financial and resource 
mechanisms and powers;  
(c) Sign an international treaty for quickest 
availability of 17 D vaccines in estimated doses 
required (may be in millions) for immediate 
vaccinations, as and when required. In addition, 
an arrangement may also be made at national 
level among vaccine manufacturers to supply 
17D vaccine, when needed at short notice;  
(d) Keeping a pool fund always available in the 
national health budget for smooth and fast 
availability of ear marked funds for the purpose 
of initiating a prevention and control 
programme on a large scale in the country;  
(e) Inter ministerial commitments and related 
measures by all the concerned departments for 
ensuring and supervising the surveillance of 
yellow fever, round the clock, at all airports, 
seaports and land entry points in the country. 
Illegal immigrants, who mostly remain 
unchecked if not caught, also pose threats since 
their status of travel to and fro to India from 
endemic countries remains unknown, 
undetected and therefore make the population 
vulnerable for infection and disease; 
  (f) At least dual checks at all national entry 
points for a valid ‘International Certificate of 
Yellow Fever Vaccination’ for travelers directly 
or indirectly immigrating in India from endemic 
countries;  
(g) Ensuring all possible ways of vector control 
i.e. aedes aegypti in the country through 
awareness campaigns, training of health staff, 
rigorous surveillance & monitoring of all arbo-
viral diseases known to be prevalent in India;  
(h) Conducting large scale research studies to 
evaluate the level of protection provided for 
yellow fever, if any, by Japanese Encephalitis 
Vaccine being used for immunization purposes 
towards protection from Japanese Encephalitis. 
The role of ‘genetic factors’ as well as ‘cross 
immunity’ may also be evaluated as a research 
study. Indian Aedes mosquitoes may be less 
efficient vectors than those of Africa and South 
America. Indians might have developed cross 
immunity by suffering from other arboviral 
diseases such as Dengue fever, Kyasanur Forest 
Disease (KFD) and Japanese Encephalitis (JE), 
which has provided an ‘ecological barrier’.  
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Indians might have developed antimosquito 
antibodies, following bites by Aedes 
mosquitoes.10 However, all these assumptions 
require well designed and thorough 
epidemiological, entomological and clinical 
studies;  
(i) Surveying areas for ‘IgM/IgG antibody titres’ 
against yellow fever, where sub-clinical 
infection may be anticipated particularly near 
the port or entry point with ‘Aedes Aegypti 
Index’ more than 1, the value of which should 
necessarily be below 1 in all endemic countries.  
(j) Surveying adventurous home tourist 
returning from their tours in yellow fever 
endemic countries for any sub-clinical infection;  
(k) Ensuring all other measures, as 
suggested/recommended from time to time by 
various ‘Associations, Agencies, Teaching & 
Research Institutions of Public Health Experts of 
India’. 
 
CONCLUSION 
The grave threats posed by yellow fever require 
urgent, immediate and comprehensive public 
health attention. Yellow fever has not yet 
entered in India. No stone should be left 
unturned for checking the entry of yellow fever 
in India. The systems, expertise and services put 
in place for prevention and control of yellow 
fever in India shall go a long way in minimizing 
the health, developmental and economic 
adversities in India.  
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